Recombinant Human Adenovirus Type 5
Sponsors
Beijing Tsinghua Chang Gung Hospital, The First Affiliated Hospital of Bengbu Medical University, Henan Cancer Hospital
Conditions
Cholangiocarcinoma, IntrahepaticHepatocellular CarcinomaNon-small Cell Lung Cancer
Phase 2
Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
Not yet recruitingNCT06253598
Start: 2024-03-30End: 2026-12-30Target: 30Updated: 2024-03-07
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Not yet recruitingNCT06618391
Start: 2024-10-08End: 2026-10-30Target: 84Updated: 2024-10-01